Insider · CIK 0001742616

Okey Stephanie

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001742616

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,400 sh	$85.00	−$544K	5,925
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,925 sh	$85.00	−$504K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	$60.85	−$1.52M	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$61.77	−$772K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	$64.77	−$1.13M	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	$64.68	−$1.13M	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$40.29	−$504K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.4K sh	$52.67	−$545K	0
2026-09-01	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,730 sh	$49.13	−$478K	0
2026-06-18	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+5,925 sh	—	—	12,325
2026-06-18	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,730 sh	—	—	9,730
2026-06-17	CRNXCrinetics Pharmaceuticals, Inc.S Sale	Director	SSale	−6,292 sh	$35.62	−$224K	7,008
2026-06-17	CRNXCrinetics Pharmaceuticals, Inc.S Sale	Director	SSale	−608 sh	$36.22	−$22K	6,400
2026-03-10	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,167 sh	$33.63	+$39.2K	9,167
2026-03-10	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−1,167 sh	$70.00	−$81.7K	8,000
2026-03-10	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+14K sh	$33.63	+$471K	22,000
2026-03-10	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−14K sh	$70.00	−$980K	8,000
2026-03-10	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,167 sh	—	—	0
2026-03-10	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14K sh	—	—	0
2026-03-05	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−6,333 sh	$63.38	−$401K	8,000
2026-03-03	CRNXCrinetics Pharmaceuticals, Inc.S Sale	Director	SSale	−3,000 sh	$39.67	−$119K	13,300
2026-01-02	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	12,000
2026-01-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,475 sh	—	—	3,475
2025-11-20	PTCTPTC THERAPEUTICS, INC.G Gift	Director	GGift	−867 sh	—	—	8,000
2025-06-11	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+6,900 sh	—	—	16,300
2025-06-11	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,350
2025-03-13	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−5,000 sh	$54.00	−$270K	8,867
2025-01-03	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	13,867
2025-01-03	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,800 sh	—	—	8,800
2024-12-18	Catalent, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−12.6K sh	—	—	0
2024-10-30	Catalent, Inc.A Award	Director	AAward	+4,663 sh	—	—	12,635
2024-06-07	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+3,400 sh	—	—	9,400
2024-06-07	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-03-28	CRNXCrinetics Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	$18.29	+$320K	23,500
2024-03-28	CRNXCrinetics Pharmaceuticals, Inc.S Sale	Director	SSale	−17.5K sh	$46.38	−$812K	6,000
2024-03-28	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	—	—	0
2024-02-15	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	9,867
2024-02-15	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-10-27	Catalent, Inc.A Award	Director	AAward	+6,993 sh	—	—	7,972
2023-08-28	Catalent, Inc.A Award	Director	AAward	+979 sh	—	—	979
2023-06-16	CRNXCrinetics Pharmaceuticals, Inc.A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-06-16	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2023-01-05	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	5,867
2023-01-05	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Sep 14
Okey Stephanie0001628280-26-059905
SEC(opens sec.gov)
Jun 224
Okey Stephanie0001628280-26-044708
SEC(opens sec.gov)
Jun 184
Okey Stephanie0001628280-26-044419
SEC(opens sec.gov)
Mar 124
Okey Stephanie0001742616-26-000006
SEC(opens sec.gov)
Mar 94
Okey Stephanie0001742616-26-000004
SEC(opens sec.gov)

Companies

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121